reports
EQS-News: Continental steigert Gewinn und treibt 2025 ihre Neuaufstell...
EQS-News: Continental AG / Schlagwort(e): Jahresergebnis/Prognose Continental steigert Gewinn und treibt 2025 ihre Neuaufstellung voran 04.03.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Konzernumsatz 39,7 Milliarden Euro (2023: 41,4 Milliarden Euro, -4,1 Prozent) Bereinigtes EBIT 2,7 Milliarden Euro (2023: 2,5 Milliarden Euro, +6,6 Prozent) Bereinigte EBIT-Marge 6,8 Prozent (2023: 6,1 Prozent) Nettoergebnis 1,2 Milliarden Euro (2023: 1,2 Milliarden Euro, +1,0 Prozent) Bereinigter Free Cashflow 1,05 Milliarden Eur...
EQS-News: Evotec gibt wichtige Fortschritte in der Neurologie-Partners...
EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec gibt wichtige Fortschritte in der Neurologie-Partnerschaft mit Bristol Myers Squibb bekannt 04.03.2025 / 07:30 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Laufende strategische Partnerschaft bringt gemeinsame Pipeline in der Neurodegenerationsforschung voran Evotec erhält eine Zahlung von 20 Millionen Dollar, um die Forschung weiter voranzutreiben Hamburg, 04 März 2025: Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: ...
EQS-News: Evotec Announces Key Progress in Neuroscience Collaboration ...
EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec Announces Key Progress in Neuroscience Collaboration with Bristol Myers Squibb 04.03.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Ongoing strategic partnership advances joint pipeline in neurodegeneration research Evotec receives a $20 million payment to further progress research Hamburg, Germany, 04 March 2025: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced another major accomplishment in it...
EQS-News: Continental Increases Profit and Drives Forward Realignment ...
EQS-News: Continental AG / Key word(s): Annual Results/Forecast Continental Increases Profit and Drives Forward Realignment in 2025 04.03.2025 / 07:30 CET/CEST The issuer is solely responsible for the content of this announcement. Consolidated sales of €39.7 billion (2023: €41.4 billion, -4.1 percent) Adjusted EBIT of €2.7 billion (2023: €2.5 billion, +6.6 percent) Adjusted EBIT margin of 6.8 percent (2023: 6.1 percent) Net income of €1.2 billion (2023: €1.2 billion, +1.0 percent) Adjusted free cash flow of €1.05 billion (2023: €1.3 billion, -18.6 percent) CEO Nikol...
Lehto Group Plc: 1 director
A director at Lehto Group Plc sold 2,900,000 shares at 0.200EUR and the significance rating of the trade was 63/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
EQS-News: Fielmann-Gruppe: Vorläufige Zahlen des Geschäftsjahrs 2024
EQS-News: Fielmann Group AG / Schlagwort(e): Vorläufiges Ergebnis Fielmann-Gruppe: Vorläufige Zahlen des Geschäftsjahrs 2024 04.03.2025 / 07:28 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Fielmann-Gruppe: Vorläufige Zahlen des Geschäftsjahrs 2024Umsatz steigt um +15 % auf 2,3 Milliarden €, operatives Ergebnis um +23 % Vorläufige Zahlen liegen im Rahmen der im Juli 2024 kommunizierten Erwartungen Bereinigtes EBITDA der Gruppe steigt +23 %, Marge in Europa erreicht 22,8 % (+2,1 Prozentpunkte) Starkes Wachstum der Augenvorsorge...
EQS-News: Fielmann Group preliminary financials for FY2024
EQS-News: Fielmann Group AG / Key word(s): Preliminary Results Fielmann Group preliminary financials for FY2024 04.03.2025 / 07:28 CET/CEST The issuer is solely responsible for the content of this announcement. Fielmann Group preliminary financials for FY2024Sales grow +15% to € 2.3 billion, profitability jumps +23% FY2024 preliminary numbers in line with capital market guidance published in July 2024 Group adj. EBITDA grows by 23%, in Europe the margin is up +2.1 %pt. (to 22.8%) Primary eyecare grows rapidly in Europe: already 130,000 Eye Health Check Ups In 2024, the...
Transaction in Own Shares
Transaction in Own Shares ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 04 March 2025 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited. Aggregated information Dates of purchase:03 March 2025Aggregate number of ordinary shares of USD 0.01 each purchased:80,000Lowest price paid per share (GBp): 1,540.00Highest price paid per share (GBp): 1,592.00Volume weighted average price paid per share (GBp): 1,567.45 Followin...
ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support fr...
ONWARD Medical to Advance Parkinson’s Disease Pipeline with Support from The Michael J. Fox Foundation and US Department of Defense The Michael J. Fox Foundation for Parkinson’s Research is supporting a study addressing mobility challenges in Parkinson’s disease; the first participant was enrolled in late 2024 A US Department of Defense grant will support a study addressing blood pressure instability; first enrollment is expected in 1H 2025 These studies both explore whether the ONWARD ARC-IM System has the potential to offer benefit beyond spinal cord injury EINDHOVEN, the Netherlands, ...
- Ewa Manthey
- Warren Patterson
The Commodities Feed: OPEC+ set to increase supply
Oil prices are weaker as OPEC+ confirms it will start reversing supply cuts, while tariff uncertainty is also hitting sentiment
INOX India Ltd: 1 director
A director at INOX India Ltd sold 80,000 shares at 906.342INR and the significance rating of the trade was 76/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly...
EQS-News: KTM AG startet neu in die Zukunft – Stefan Pierer übergibt a...
EQS-News: KTM AG / Schlagwort(e): Personalie KTM AG startet neu in die Zukunft – Stefan Pierer übergibt an Gottfried Neumeister 04.03.2025 / 07:15 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Corporate News KTM AG startet neu in die Zukunft – Stefan Pierer übergibt an Gottfried Neumeister Stefan Pierer legt Vorstandsmandat in der KTM AG zurück und übergibt die Führung der KTM AG vollständig an Gottfried Neumeister Verena Schneglberger-Grossmann in den Vorstand gewählt Mattighofen, 4. März 2025 – Die KTM AG gibt heute d...
EQS-News: KTM AG makes a new start into the future – Stefan Pierer han...
EQS-News: KTM AG / Key word(s): Personnel KTM AG makes a new start into the future – Stefan Pierer hands over to Gottfried Neumeister 04.03.2025 / 07:15 CET/CEST The issuer is solely responsible for the content of this announcement. Corporate News KTM AG makes a new start into the future – Stefan Pierer hands over to Gottfried Neumeister Stefan Pierer resigns from the Executive Board of KTM AG and hands over the management of KTM AG completely to Gottfried Neumeister Verena Schneglberger-Grossmann elected to the Executive Board Mattighofen, March 4, 2025 - KTM...
Fawry For Banking Technology And Electronic Payment: 1 director
A director at Fawry For Banking Technology And Electronic Payment bought 956,751 shares at 0.000EGP and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's dir...
Cleopatra Hospital: 1 director
A director at Cleopatra Hospital sold 150,000 shares at 0.000EGP and the significance rating of the trade was 52/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Misr Hotels (Hilton): 1 director
A director at Misr Hotels (Hilton) bought/sold 605,647 shares at 0.000EGP and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...
Guangdong Hoshion Aluminium Co Ltd: 1 director
A director at Guangdong Hoshion Aluminium Co Ltd sold 1,241,500 shares at 20.800CNY and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the ...
- Thijs Berkelder
- Kasemsun Koonnara
Pruksa Holding (PSH TB) - Aggressive Launches For 2025 But Challenges ...
PSH has planned an aggressive strategy for 2025 with 22 new projects worth Bt23.4b (+29% yoy), aiming to drive growth. While an earnings recovery is expected in 2025, challenges remain, particularly from high mortgage rejection rates and margin pressure due to price promotions. 1Q25 earnings are projected to be flat yoy at an abnormally low level but profitable qoq, in which overall transfers and gross margins are likely to remain under pressure. Maintain SELL. Target price: Bt4.70.
Eurasia Travel Co: 1 director
A director at Eurasia Travel Co sold 100,000 shares at 475.000JPY and the significance rating of the trade was 50/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.